Trials / Completed
CompletedNCT01544686
Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients
Chlorhexidine Containing Iv-securement Dressings for the Prevention of Central Venous Catheter-related Blood Stream Infections in Neutropenic Patients: a Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 630 (actual)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In neutropenic cancer patients, catheter-related bloodstream infections may cause severe infections and even death. To assess the prophylactic effect of a chlorhexidine coated catheter securement dressing on the incidence of catheter-related bloodstream infections, this open, randomized trial is being carried out. CHG iv Tegaderm securement dressing will be randomized in a 1:1 fashion against Tegaderm Advanced iv securement dressing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3M™ Tegaderm™ CHG IV and 3M™ Tegaderm™ Advanced IV | Patients receive the 3M™ Tegaderm CHG IV securement dressing or the 3M Tegaderm Advanced IV securement dressing after placement of a central venous catheter. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2012-03-06
- Last updated
- 2015-12-09
Locations
5 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01544686. Inclusion in this directory is not an endorsement.